BioPharma Inc Cambrian, a 10% owner of $SNSE, sold 476 shares of the company on 06-01-2026 for an estimated $10,062. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.4% of their shares of this class of stock. Following this trade, they now own 130,142 shares of this class of $SNSE stock.
$SNSE Insider Trading Activity
$SNSE insiders have traded $SNSE stock on the open market 71 times in the past 6 months. Of those trades, 26 have been purchases and 45 have been sales.
Here’s a breakdown of recent trading of $SNSE stock by insiders over the last 6 months:
- MANAGEMENT LLC MILLENNIUM has made 26 purchases buying 46,980 shares for an estimated $1,341,720 and 25 sales selling 23,067 shares for an estimated $704,453.
- BIOPHARMA INC CAMBRIAN has made 0 purchases and 10 sales selling 52,907 shares for an estimated $787,807.
- JAMES PEYER has made 0 purchases and 10 sales selling 52,907 shares for an estimated $787,807.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$SNSE Hedge Fund Activity
We have seen 22 institutional investors add shares of $SNSE stock to their portfolio, and 2 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WOODLINE PARTNERS LP added 361,010 shares (+inf%) to their portfolio in Q1 2026, for an estimated $11,379,035
- CORMORANT ASSET MANAGEMENT, LP added 306,222 shares (+inf%) to their portfolio in Q1 2026, for an estimated $9,652,117
- MILLENNIUM MANAGEMENT LLC added 146,565 shares (+inf%) to their portfolio in Q1 2026, for an estimated $4,619,728
- FRANKLIN RESOURCES INC added 133,506 shares (+inf%) to their portfolio in Q1 2026, for an estimated $4,208,109
- CALIGAN PARTNERS LP added 126,002 shares (+inf%) to their portfolio in Q1 2026, for an estimated $3,971,583
- MARSHALL WACE, LLP added 65,730 shares (+inf%) to their portfolio in Q1 2026, for an estimated $2,071,809
- GOLDMAN SACHS GROUP INC added 61,568 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,940,623
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$SNSE Analyst Ratings
Wall Street analysts have issued reports on $SNSE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 05/29/2026
To track analyst ratings and price targets for $SNSE, check out Quiver Quantitative's $SNSE forecast page.
$SNSE Price Targets
Multiple analysts have issued price targets for $SNSE recently. We have seen 2 analysts offer price targets for $SNSE in the last 6 months, with a median target of $52.5.
Here are some recent targets:
- Christopher Liu from LUCID CAPITAL MARKETS set a target price of $50.0 on 05/28/2026
- Samantha Semenkow from Citigroup set a target price of $55.0 on 05/22/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
